ACP6-12 is a ClpP activator and antibiotic. Its activity is over ten times greater than the initial compound ACP1-06. This enhanced activity has been confirmed by the co-crystal X-ray structure with ClpP, validating its predicted binding conformation. This evidence supports comparisons of how different ligand classes bind to the hydrophobic binding site.